All industries, including biotechnology, are faced with a drastically different economic environment from that of four or five years ago. To get a sense of how a key biotech supplier that operates on ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

On Saturday, Rami Elghandour learned that the university had canceled his speech after complaints over his social media posts ...

The Biotechnology Innovation Organization’s CEO John Crowley isn’t shying away from the tough tasks. With only a little more than three months at the helm of the world’s largest biotech advocacy group ...

Liisa Bayko is a managing director and research analyst at Evercore ISI covering mid- and small-cap biotechnology companies. In 2022, she debuted on Institutional Investor’s All-America Research poll ...

Biotech interviews in 2026 demand more than just lab expertise—they assess critical thinking, communication, and the ability to operate within regulatory and fast-paced environments. Employers seek ...

Recursion is hosting about 60 investors and analysts at its headquarters in Utah. It has generated tons of data with AI and robots, aiming to find a better way to make drugs. Recursion, which has four ...